SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 24, 2015
Axiom Corp.
(Exact name of registrant as specified in its charter)
|
Colorado |
|
333-186078 |
|
N/A |
|
(State or other jurisdiction |
|
(Commission File Number) |
|
(IRS Employer |
|
of Incorporation) |
|
|
|
Identification Number) |
|
|
|
|
|
|
380 Vansickle Rd. Unit 600
St. Catherines, ON
Canada L2S 0B5
Tel. 905-646-8781
(Address, including zip code, and telephone number, including area code,
of registrant's principal executive offices)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
£ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
£ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
£ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
£ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Page 1 of 2
SECTION 8 – OTHER INFORMATION
ITEM 8.02 – OTHER INFORMATION
On March 24, 2015, OTC Markets informed us that it has become aware of certain extreme promotional activity of our stock, which may have included spam emails, news releases or newsletters by third parties. This promotional activity has apparently resulted in drastic fluctuations in our stock price and high trading volume. As a result, OTC Markets has placed a caveat emptor label on our ticker symbol to warn the public. We are not fully aware of the nature and content of this promotional activity, who is behind it and the extent of its dissemination. While we file press releases in the ordinary course of our business to inform the public of our current business activities, which we feel is prudent as a public company, the promotional activities of these third parties have raised a public concern. We intend to continue to stay in contact with the OTC Markets about this concern and work to remove the caveat emptor label from our ticket symbol.
The OTC Markets correspondence is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.
SECTION 9 – FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
99.1 OTC Markets correspondence dated March 24, 2015
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Axiom Corp.
Dated: March 25, 2015 /s/ Tyler Pearson
By: Tyler Pearson
Its: Chief Executive Officer
Page 2 of 2
Exhibit 99.1
Dear Axiom Corp.,
Your company has been labeled with Caveat Emptor at http://www.otcmarkets.com/stock/AXMM/profile as a warning to investors for the following reason:
Public Interest Concern: OTC Markets Group has become aware of promotion regarding your security having the effect of encouraging trading of your securities in the OTC market. As a matter of policy, when it has come to the attention of OTC Markets that a security has been the subject of extreme promotion, OTC Markets may at its discretion label a security "Caveat Emptor." Promotional activities may include spam emails or mails, news releases and/or newsletters, whether they are published by the issuer or a third party.
The Caveat Emptor symbol (a Skull and Crossbones icon) will remain on the company profile until OTC Market Group believes there is no longer a public interest concern and the company remains qualified for either OTC Pink Current Information or OTCQB.
Companies can maintain their tier by doing the following:
SEC Reporting companies must be current in their reporting obligations to the SEC through the EDGAR system.
Non-SEC Reporting companies must use the OTC Disclosure and News Service to make adequate current information available pursuant to the OTC Pink Basic Disclosure Guidelines and publish an Attorney Letter pursuant to the Attorney Letter Guidelines. The attorney letter must include responses to Exhibit B, Items 14 & 15.
During the time it is labeled Caveat Emptor; quotations will not be published on otcmarkets.com for any security that is not in OTC Pink Current Information or OTCQB.
If you need further information, contact Issuer Services at issuers@otcmarkets.com or (212) 896-4420.
Thank you,
Corporate Services
OTC Markets Group
100 M Street SE, Suite 220 / Washington, DC 20003
Office: (212) 896-4420
Email: issuers@otcmarkets.com
Website: http://www.otcmarkets.com/home
Twitter: https://twitter.com/OTCMarkets
Facebook: https://www.facebook.com/OTCMarkets
LinkedIn: https://www.linkedin.com/company/otc-markets-group